Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Q1 Earnings In Brief: Celgene, Alkermes, Novo Nordisk, Acorda, Alexion

Apr 29 2016

• By Lisa LaMotta and Joseph Haas

Related Content

Alkermes' Aristada Seeks Differentiation After Launch

Feb 26 2016

Will Novo's LEADER Trial Move GLP-1 To The Diabetes Front Line?

Mar 05 2016

Editorial: Counting The Impact Of I-O Entrants

Nov 12 2015

Related Companies

Bristol Myers Squibb Company

Merck & Co., Inc.

Bristol Myers Squibb Company

Alkermes plc

Johnson & Johnson

Otsuka Holdings Co., Ltd.

H. Lundbeck A/S

Novo Nordisk A/S

Eli Lilly and Company

Acorda Therapeutics, Inc.

Alexion Pharmaceuticals Inc.

Synageva BioPharma Corp.

Additional Topics

United States Companies Business Strategies Clinical Trials

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window